Literature DB >> 29725858

Zebrafish heart failure models: opportunities and challenges.

Xingjuan Shi1,2,3, Ru Chen4, Yu Zhang4, Junghwa Yun5,6, Koroboshka Brand-Arzamendi5,6, Xiangdong Liu4, Xiao-Yan Wen5,6.   

Abstract

Heart failure is a complex pathophysiological syndrome of pumping functional failure that results from injury, infection or toxin-induced damage on the myocardium, as well as genetic influence. Gene mutations associated with cardiomyopathies can lead to various pathologies of heart failure. In recent years, zebrafish, Danio rerio, has emerged as an excellent model to study human cardiovascular diseases such as congenital heart defects, cardiomyopathy, and preclinical development of drugs targeting these diseases. In this review, we will first summarize zebrafish genetic models of heart failure arose from cardiomyopathy, which is caused by mutations in sarcomere, calcium or mitochondrial-associated genes. Moreover, we outline zebrafish heart failure models triggered by chemical compounds. Elucidation of these models will improve the understanding of the mechanism of pathogenesis and provide potential targets for novel therapies.

Entities:  

Keywords:  Cardiomyopathy; Chemical compound; Heart failure; Mitochondria; Sarcomere; Zebrafish

Mesh:

Year:  2018        PMID: 29725858     DOI: 10.1007/s00726-018-2578-7

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  7 in total

Review 1.  Human-induced pluripotent stem cells for modelling metabolic perturbations and impaired bioenergetics underlying cardiomyopathies.

Authors:  Chrishan J A Ramachandra; Jasper Chua; Shuo Cong; Myu Mai Ja Kp; Winston Shim; Joseph C Wu; Derek J Hausenloy
Journal:  Cardiovasc Res       Date:  2021-02-22       Impact factor: 10.787

Review 2.  Cellular and Animal Models of Striated Muscle Laminopathies.

Authors:  Hannah A Nicolas; Marie-Andrée Akimenko; Frédérique Tesson
Journal:  Cells       Date:  2019-03-29       Impact factor: 6.600

Review 3.  Zebrafish Models of Cancer Therapy-Induced Cardiovascular Toxicity.

Authors:  Sarah Lane; Luis Alberto More; Aarti Asnani
Journal:  J Cardiovasc Dev Dis       Date:  2021-01-22

Review 4.  Mechanisms of TTNtv-Related Dilated Cardiomyopathy: Insights from Zebrafish Models.

Authors:  Celine F Santiago; Inken G Huttner; Diane Fatkin
Journal:  J Cardiovasc Dev Dis       Date:  2021-01-25

5.  STVNa Attenuates Isoproterenol-Induced Cardiac Hypertrophy Response through the HDAC4 and Prdx2/ROS/Trx1 Pathways.

Authors:  Fei Liu; Hao Su; Bo Liu; Ying Mei; Qingjin Ke; Xiaoou Sun; Wen Tan
Journal:  Int J Mol Sci       Date:  2020-01-20       Impact factor: 5.923

Review 6.  Alternative strategies in cardiac preclinical research and new clinical trial formats.

Authors:  Fabian Philipp Kreutzer; Anna Meinecke; Kevin Schmidt; Jan Fiedler; Thomas Thum
Journal:  Cardiovasc Res       Date:  2022-02-21       Impact factor: 10.787

7.  ndufa7 plays a critical role in cardiac hypertrophy.

Authors:  Xingjuan Shi; Yu Zhang; Ru Chen; Yijie Gong; Mingming Zhang; Rui Guan; Ori D Rotstein; Xiangdong Liu; Xiao-Yan Wen
Journal:  J Cell Mol Med       Date:  2020-09-29       Impact factor: 5.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.